021-51111890
购物车（）
sales@molnova.cn
Vopratelimab
CAS No. 2039148-04-2
Vopratelimab ( —— )
产品货号. M36893 CAS No. 2039148-04-2
Vopratelimab (JTX-2011) 是一种人源化免疫球蛋白 G1-kappa 激动剂单克隆抗体，特异性结合到诱导型 T 细胞 CO 刺激因子 (ICOS)。Vopratelimab 保留了物种交叉反应性，对 hICOS 的亲和力为 0.93 nM，对大鼠 ICOS 的亲和力为 3.7 nM，对 mICOS 的亲和力为 0.64 nM。Vopratelimab 具有抗肿瘤免疫反应。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥6897 | 有现货 |
|
| 10MG | ￥9301 | 有现货 |
|
| 25MG | ￥13485 | 有现货 |
|
| 50MG | ￥18228 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Vopratelimab
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Vopratelimab (JTX-2011) 是一种人源化免疫球蛋白 G1-kappa 激动剂单克隆抗体，特异性结合到诱导型 T 细胞 CO 刺激因子 (ICOS)。Vopratelimab 保留了物种交叉反应性，对 hICOS 的亲和力为 0.93 nM，对大鼠 ICOS 的亲和力为 3.7 nM，对 mICOS 的亲和力为 0.64 nM。Vopratelimab 具有抗肿瘤免疫反应。
-
产品描述Vopratelimab (JTX-2011) is a humanized immunoglobulin G1-kappa agonist monoclonal antibody that pecifically binds to the Inducible CO-Stimulator of T cells (ICOS). Vopratelimab retains species cross-reactivity with affinities of 0.93 nM to hICOS, 0.46 nM to cynomolgus ICOS, 3.7 nM to rat ICOS, and 0.64 nM to mICOS. Vopratelimab has antitumor immune response.
-
体外实验——
-
体内实验Animal Model:Female A/J, Balb/c and C57BL/6 mice with Sa1/N murine syngeneic tumor model Dosage:0.25-0.3 mg/kg Administration:Intraperitoneal injection; twice a week, for 2 weeks Result:Regressed tumor and protected long-term in the Sa1/N murine syngeneic tumor model.
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Others
-
研究领域——
-
适应症——
化学信息
-
CAS Number2039148-04-2
-
分子量
-
分子式——
-
纯度>98% (HPLC)
-
溶解度——
-
SMILES——
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Hanson A, et, al. ICOS agonism by JTX-2011 (vopratelimab) requires initial T cell priming and Fc cross-linking for optimal T cell activation and anti-tumor immunity in preclinical models. PLoS One. 2020 Sep 24;15(9):e0239595.?
产品手册
关联产品
-
Compound 10w
Compound 10w, a substituted pyrazolo[1,5-a]pyrimidinamide compound, is a ZSTK474 analog that shows anticancer activity against HeLa cells.
-
1-vinylpyrene
1-vinylpyrene (1-Ethenylpyrene) has antitumor activity and strongly inhibits the formation of skin tumors triggered by DMBA or B[]P in a dose-dependent manner and can be used to prevent tumor formation.
-
BPP 5a
Bradykinin potentiator-5 is a peptide inflammatory mediator, causes blood vessels to dilate (enlarge), and therefore causes blood pressure to fall.
